Form 4: Health Catalyst COO Daniel LeSueur Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Health Catalyst's Chief Operating Officer, Daniel LeSueur, sold 16,902 shares of common stock at a price of $4.5161 per share on March 5, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On March 5, 2025, Daniel LeSueur, the Chief Operating Officer of Health Catalyst, Inc. (HCAT), sold 16,902 shares of the company's common stock.
- The transaction was executed at a price of $4.5161 per share.
- Following the sale, LeSueur directly owns 216,250 shares of Health Catalyst.
- The sale was conducted under a pre-arranged trading plan established on March 7, 2024, in accordance with Rule 10b5-1.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider stock sale. It doesn't inherently convey positive or negative sentiment, as it's simply a disclosure of a transaction.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company executives and their holdings in the company. The use of a 10b5-1 trading plan is a common practice to allow insiders to sell shares without being accused of trading on non-public information.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Date the reporting person adopted a written trading plan in accordance with Rule 10b5-1 |
| 03/05/2025 | Date of the transaction (stock sale) |
| 03/10/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.